The Biotech Growth Trust PLC
BIOG.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$29.97B
Close$
$-51.84
103.7% downside
Current Fair Value
103.7% downsideOvervalued by 103.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $29.97 Billion |
|---|---|
| Enterprise Value | $29.99 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.58 |
| Beta | 0.61 |
| Outstanding Shares | 21,317,778 |
Return
| Return on Equity | 16.88% |
|---|---|
| Return on Assets | 15.75% |
| Return on Invested Capital | 17.84% |
Valuation & Multiples
| P/E Ratio | 2.51 |
|---|---|
| PEG | -1.5 |
| Price to Sales | 703.0 |
| Price to Book Ratio | 108.15 |
| Enterprise Value to Revenue | 507.9 |
| Enterprise Value to EBIT | 579.84 |
| Enterprise Value to Net Income | 630 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About The Biotech Growth Trust PLC
0
CEO: Samuel David Isaly The Biotech Growth Trust PLC, a closed-ended equity investment vehicle, was originally established by Frostrow Capital LLP and is jointly managed by OrbiMed Capital LLC. Formed on May 20, 1997, and legally based in the United Kingdom, th...